REQUEST A DEMO
Total
USD $0.00
Search more companies

Jiangsu Lianhuan Pharmaceutical Co.,Ltd. (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Jiangsu Lianhuan Pharmaceutical Co.,Ltd. Profile Updated: October 27, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

The main products are one type of New Drug epristeride, two types of drugs terfenadine and Mitel (terfenadine tablets), three new drugs linked ring (the United States more pseudoephedrine capsules), fThe drug felodipine and associated fixed ring Seoul (felodipine tablets) in 16 state-level new drugs. The company has three GMP standard with modern production plant.All products have passed the National GMP certification, felodipine to equal export varieties have been successfully registered in the U.S. FDA. In addition, the company's Bio-Engineering Co., Ltd. Yangzhou Wick with avian influenza inactivated vaccine (H9 Subtype, F strain), infectious bursal moderate virulence vaccine (NF8 strain), Marek's disease vaccine (CVI988 strains), gosling plague vaccine (goose use), and six Department of Agriculture veterinary vaccine products obtained production approval and put into production.

Headquarters
No. 9, Health 1st Road, Biological Health Industrial Park, Yangzhou City, Jiangsu Province
Yangzhou; Jiangsu; Postal Code: 225127

Contact Details: Purchase the Jiangsu Lianhuan Pharmaceutical Co.,Ltd. report to view the information.

Website: http://www.lhpharma.com

Basic Information
Total Employees:
Purchase the Jiangsu Lianhuan Pharmaceutical Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Jiangsu Lianhuan Pharmaceutical Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Jiangsu Lianhuan Pharmaceutical Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Jiangsu Lianhuan Pharmaceutical Co.,Ltd. report to view the information.
Incorporation Date:
February 22, 2000
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
38.09%
Purchase this report to view the information.
1.31%
Purchase this report to view the information.
0.7%
Purchase this report to view the information.
0.62%
Purchase this report to view the information.
0.62%
Subsidiaries
Chengdu Yazhong Biopharmaceutical Co., Ltd.
Jiangsu Lianhuan Biological Medicine Co., Ltd.
Jiangsu Lianhuan Jijia Technology Co., Ltd.
Company Performance
Financial values in the chart are available after Jiangsu Lianhuan Pharmaceutical Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
10.87%
Total operating revenue
10.6%
Operating profit (EBIT)
4.33%
Net Profit (Loss) for the Period
6.9%
Total assets
8.02%
Total equity
7.6%
Operating Profit Margin (ROS)
-0.46%
Net Profit Margin
-0.24%
Return on Equity (ROE)
-0.05%
Debt to Equity Ratio
2.32%
Quick Ratio
-0.09%
Cash Ratio
-0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?